Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
21,021,835
-
Share change
-
-390,198
-
Total reported value
-
$2,933,097,040
-
Put/Call ratio
-
207%
-
Price per share
-
$139.54
-
Number of holders
-
245
-
Value change
-
-$42,949,065
-
Number of buys
-
151
-
Number of sells
-
62
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q2 2018
As of 30 Jun 2018,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
245 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,021,835 shares.
The largest 10 holders included
Capital Research Global Investors, Capital World Investors, SCOPIA CAPITAL MANAGEMENT LP, PRUDENTIAL PLC, PRICE T ROWE ASSOCIATES INC /MD/, LORD, ABBETT & CO. LLC, JANUS HENDERSON GROUP PLC, BlackRock Inc., JENNISON ASSOCIATES LLC, and BANK OF AMERICA CORP /DE/.
This page lists
245
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.